Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent

Leuk Res. 2007 Sep;31(9):1321-3. doi: 10.1016/j.leukres.2006.10.006. Epub 2006 Nov 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Bone Marrow Transplantation*
  • Cell Differentiation / drug effects*
  • Female
  • Humans
  • Myelodysplastic Syndromes / therapy*
  • Vitamin D / analogs & derivatives*
  • Vitamin D / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • dihydroxy-vitamin D3
  • Vitamin D
  • Azacitidine